Critically ill COVID-19 patients who received a single dose of a drug that calms an overreacting immune system were 45% less likely to die overall, and more likely to be out of the hospital or off a ventilator one month after treatment, compared with those who didn’t receive the drug, a new study finds. The lower risk of death happened despite the fact that the patients were also twice as likely to develop another infection.
Source: Drug linked to 45% lower risk of dying among COVID-19 patients on ventilators
You must log in to post a comment.